Header

Speakers 


John Ansell, Senior Partner, TranScrip Partners

Sultan Aziz, Senior Director, Capacity Management, Janssen Pharmaceuticals

Scott Babler, Strategic Realization Manager, Integrated Project Management Company, Inc.

Greg Bayer, Group Director, R&D Scheduling & Resource Management, Bristol-Myers Squibb

Richard Bayney, Ph.D., President & Founder, Project & Portfolio Value Creation; former Vice President, Portfolio Management & Decision Analysis, Johnson & Johnson

Joseph Billitti, Ph.D., MBA, Executive Director, Strategy and Operations, Global Research & Development, Pfizer

Beau Bush, President, OZMOSI

Pasquale Cetera, Consultant, MKTG Pharmaceuticals; former Vice President, Portfolio Management and Strategy, Merck

Jeffrey Davis, M.D., Director, Human Health and Performance (HH&P), CMO, NASA Johnson Space Center

Melquiades (Mel) de Jesus, Director, Business Capabilities, R&D Operations, Bristol-Myers Squibb

Sydney Edwards, Ph.D., Head, Portfolio Management, Allergan, Inc.

Carmel Egan, Ph.D., Vice President, Project Management, Eli Lilly & Co.

Philip Fahringer, Analyst, Center for Innovation, Lockheed Martin

Jonathan Freeman, Ph.D., Senior Vice President, Head, Portfolio Management, Merck Serono

Keith Friend, Ph.D., Senior Director Medical Affairs, Otsuka (OAPI)

Krish Ghosh, Ph.D., Vice President, Informatics, Covance

Arkady Gusev, Ph.D., US Operations Head, Biomarker Development (BMD), Translational Medicine, Novartis Institutes for BioMedical Research, Inc.

Ling He, Director, Clinical Bioanalysis, Daiichi Sankyo Pharma Development

Hartmut Hein, Ph.D., Director, Global Planning Office, Merck KGaA

Rafiqul Islam, Senior Director, Global Bioanalytical Services, Celerion, Inc.

Elayne Ko, Director, Portfolio and Decision Analysis, Pfizer

William Korinek, Ph.D., Vice President, Worldwide R&D Business Operations, Pfizer

John LaMattina, Senior Partner, PureTech Ventures; former President, R&D, Pfizer

Sam Mathew, MBA, Portfolio Capacity Management Leader, Finance/PMO, Janssen Pharmaceuticals

Maureen McNamara, Executive Director, Global Project Management, Merck Research Laboratories

Carlos Nunes, Director, Portfolio & Decision Analysis, Portfolio & Commercial Operations, Pfizer

David Parker, Ph.D., Vice President, Market Access Strategy, Precision for Medicine

John Phillips, Director, Capital Efficiency, Business Valuation Consulting, Deloitte Transactions & Business Analytics

William Ramos, Executive Consultant, Planisware USA

George Santangelo, Ph.D., Head, Office of Portfolio Analysis (OPA) , Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), NIH

Michael Shires, Vice President, Program and Portfolio Management, Baxter Healthcare

Richard Sonnenblick, Ph.D., CEO, Enrich Consulting

Tom Stone, Lecturer in Business, Penn State University, Abington College

Bennet Vallet, Director, Product Development, Siemens

Phil Wolf, Senior Vice President, Enterprise and On Demand Products, PDWare

Daniel Zweidler, Ph.D., Senior Fellow, Mack Institute for Innovation Management, The Wharton School, UPenn; President, DZA, Inc.